The 3,4-methylenedioxymethamphetamine enhances early visual processing for salient socio-emotional stimuli

Introduction

Haggarty and colleagues situate this study within evidence that acute 3,4-methylenedioxymethamphetamine (MDMA) increases sociability, empathy and social perception on self-report and behavioural measures, while reducing social anxiety and sensitivity to negative emotions. Previous work has proposed that MDMA's prosocial effects may involve serotonin and oxytocin systems, but the neural mechanisms mediating enhanced social processing are not fully characterised. Event-related potentials (ERPs) elicited by emotional faces—particularly the N170 (face structural encoding), P300 (attention allocation) and mismatch negativity (MMN; novelty detection)—provide a means to examine early visual and socio-emotional processing and how it is altered by psychoactive drugs. This study tested whether MDMA selectively enhances early visual processing of socio-emotional stimuli compared with a prototypic stimulant, methamphetamine (MA), and placebo. Using a double-blind, within-participant design, the investigators administered MDMA (100 mg), MA (20 mg) and placebo in separate sessions and recorded EEG during an emotional oddball faces task. The primary hypothesis was that MDMA, but not MA, would increase N170 and possibly P300 amplitudes for emotionally salient faces, indicating enhanced early processing of social cues. The work aims to clarify whether MDMA's neural effects on social processing differ from those of a standard stimulant and to inform considerations for therapeutic applications of MDMA-assisted interventions.